Latest Immunosuppressive drug Stories
A newly discovered tick-borne bacterium known as “Candidatus Neoehrlichia mikurensis” has been implicated in six cases of disease in Sweden.
WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill.
New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV.
Decision Alleviates Concerns Over Potential for Organ Rejections, Preserves Physician Discretion Over Patient Care WASHINGTON, March 13, 2014 /PRNewswire-USNewswire/ -- Kidney Care
AUSTIN, Texas, Jan. 16, 2014 /PRNewswire/ -- XBiotech announced today that it has launched a Phase II study to treat a rare but debilitating disorder, Pyoderma Gangrenosum (PG).
More than 260,000 Americans are alive today thanks to transplant operations that have replaced their failing kidneys, hearts, lungs or livers with healthy organs donated by volunteers or accident victims.
Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions.
Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk.